Russia’s Gamaleya Institute, which developed the Sputnik V coronavirus vaccine, has applied for emergency use authorization in the Philippines.
The Moscow-based company filed its application on Thursday, according to the Philippines News Agency.
A day before that, Gamaleya withdrew its application to hold clinical trials in the country, according to CNN affiliate CNN Philippines.
Gamaleya is the third vaccine maker — alongside Pfizer-BioNTech and Oxford-AstraZeneca — to apply for emergency use authorization in the Philippines.
It usually takes the Philippines’ Food and Drug Administration 21 days to decide if a drug or vaccine will be allowed for use in the country, according to CNN Philippines.
Last November, Russia said the Sputnik V vaccine was at least 91.4% effective and could be more than 95% effective, according to data from its Phase 3 trials.